ELVEDINA RIBIC: Open Payments
NPI 1033990205 · ROCHESTER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 24 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $177 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $90 |
| Amgen Inc. | 5 | $83 |
| PFIZER INC. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Lilly USA, LLC | 2 | $32 |
| Organon LLC | 1 | $17 |
| Dynavax Technologies Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| Dexcom, Inc. | 1 | $15 |
Products named: NURTEC ODT, Wegovy, OTEZLA, REXULTI, MOUNJARO, Rybelsus, VTAMA, Heplisav-B.
Industry payments across MI — which companies pay providers there.
